Accent Microcell

{
  "main_header": {
    "sid": 10039091,
    "name": "Accent Microcell",
    "stock_name": "Accent Microcell",
    "full_name": "Accent Microcell Ltd",
    "name_url": "stocks-analysis/accent-microcell",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "324.95",
    "chg": -7.5,
    "chgp": "-2.26%",
    "dir": -1,
    "prev_price": "332.45",
    "mcapval": "801.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "ACCENTMIC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0Q5D01013",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": 7000,
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/accent-microcell-10039091-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Accent Microcell overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-accent-microcell-overvalued-or-undervalued-3736687",
        "imagepath": "",
        "date": "2025-11-29 08:34:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Current Valuation Metrics and Financial Health</strong></p>\n<p>Accent Microcell trades at a price-to-earnings (PE) ratio of approximately 23.75, which is moderate within the pharmaceutical sector. Its price-to-book value stands at 3.15, indicating the market values the company at over three times its net asset value. The enterprise value to EBITDA ratio of 17.72 and EV to EBIT of 19.70 suggest a reasonable premium for operational earnings, reflecting expectations of steady profitability.</p>\n<p>The company’s return on capital employed (ROCE) is a robust 18.20%, signalling efficient use of capital to generate profits. Meanwhile, the return on equity (ROE) of 13.24% demonstrates solid shareholder returns. Dividend yield remains modest at 0.31%, consistent with a growth-oriented pharmaceutical ..."
      },
      {
        "title": "Why is Accent Microcell falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-accent-microcell-fallingrising-3736304",
        "imagepath": "",
        "date": "2025-11-29 01:09:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Outperformance Against Benchmarks</strong></p>\n<p>Accent Microcell's recent price appreciation is underscored by its impressive returns over multiple timeframes compared to the Sensex benchmark. Over the past week, the stock surged by 6.20%, significantly outpacing the Sensex's modest 0.52% gain. This momentum extends over longer periods, with the stock delivering a 22.58% return in the last month against the Sensex's 1.03%. Year-to-date, Accent Microcell has appreciated by 21.22%, nearly doubling the Sensex's 10.82% rise. Over the past year, the stock's 27.06% gain further highlights its strong performance relative to the benchmark's 9.57% increase. These figures indicate that Accent Microcell is attracting investor attention and capital inflows, driving its price higher.</p>\n<p><strong>Tec..."
      },
      {
        "title": "Why is Accent Microcell falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-accent-microcell-fallingrising-3716605",
        "imagepath": "",
        "date": "2025-11-20 00:21:40",
        "description": "As of 19-Nov, Accent Microcell Ltd's stock price is rising, currently at 327.00, reflecting an increase of 21.35 or 6.99%. The stock has recently achieved a new 52-week high of Rs. 337.95, indicating strong upward momentum. It has outperformed its sector by 6.59% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a positive trend. However, there is a notable decline in investor participation, with delivery volume dropping by 38.52% compared to the 5-day average, which may raise concerns about sustainability. The stock has shown impressive returns over various periods, including a 21.11% increase year-to-date and a 32.52% rise over the past year, significantly outperforming the Sensex.\n\nIn the broader market context, Accent Microcell's short-term return of 5.38% over the past week is substantially higher than the Sensex's return of 0.68%, indicating str..."
      },
      {
        "title": "Why is Accent Microcell falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-accent-microcell-fallingrising-3691433",
        "imagepath": "",
        "date": "2025-11-12 00:14:01",
        "description": "As of 11-Nov, Accent Microcell Ltd's stock price is rising, currently at 305.65, reflecting an increase of 10.55 or 3.58%. The stock has shown strong performance today, outperforming its sector by 1.79%. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Additionally, there has been a significant rise in investor participation, with delivery volume increasing by 96.77% compared to the 5-day average. The stock has also demonstrated impressive returns, with a 1-week increase of 6.46% and a 1-month increase of 20.33%, both significantly outperforming the Sensex.\n\nIn the broader market context, Accent Microcell's short-term performance has been notably strong compared to the benchmark, with a 1-week return of 6.46% against the Sensex's 0.38%. This trend continues over the 1-month period, where the stock's return of 20.33% far exceeds the Sensex's 1...."
      }
    ],
    "total": 93,
    "sid": "10039091",
    "stock_news_url": "https://www.marketsmojo.com/news/accent-microcell-10039091"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Accent Microcell Ltd has declared <strong>10%</strong> dividend, ex-date: 16 Sep 25",
          "dt": "2025-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Accent Microcell Ltd has announced <strong>7:50</strong> rights issue, ex-date: 04 Jun 25",
          "dt": "2025-06-04",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Is Accent Microcell overvalued or undervalued?

2025-11-29 08:34:58

Current Valuation Metrics and Financial Health

Accent Microcell trades at a price-to-earnings (PE) ratio of approximately 23.75, which is moderate within the pharmaceutical sector. Its price-to-book value stands at 3.15, indicating the market values the company at over three times its net asset value. The enterprise value to EBITDA ratio of 17.72 and EV to EBIT of 19.70 suggest a reasonable premium for operational earnings, reflecting expectations of steady profitability.

The company’s return on capital employed (ROCE) is a robust 18.20%, signalling efficient use of capital to generate profits. Meanwhile, the return on equity (ROE) of 13.24% demonstrates solid shareholder returns. Dividend yield remains modest at 0.31%, consistent with a growth-oriented pharmaceutical ...

Read full news article

Why is Accent Microcell falling/rising?

2025-11-29 01:09:54

Outperformance Against Benchmarks

Accent Microcell's recent price appreciation is underscored by its impressive returns over multiple timeframes compared to the Sensex benchmark. Over the past week, the stock surged by 6.20%, significantly outpacing the Sensex's modest 0.52% gain. This momentum extends over longer periods, with the stock delivering a 22.58% return in the last month against the Sensex's 1.03%. Year-to-date, Accent Microcell has appreciated by 21.22%, nearly doubling the Sensex's 10.82% rise. Over the past year, the stock's 27.06% gain further highlights its strong performance relative to the benchmark's 9.57% increase. These figures indicate that Accent Microcell is attracting investor attention and capital inflows, driving its price higher.

Tec...

Read full news article

Why is Accent Microcell falling/rising?

2025-11-20 00:21:40

As of 19-Nov, Accent Microcell Ltd's stock price is rising, currently at 327.00, reflecting an increase of 21.35 or 6.99%. The stock has recently achieved a new 52-week high of Rs. 337.95, indicating strong upward momentum. It has outperformed its sector by 6.59% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a positive trend. However, there is a notable decline in investor participation, with delivery volume dropping by 38.52% compared to the 5-day average, which may raise concerns about sustainability. The stock has shown impressive returns over various periods, including a 21.11% increase year-to-date and a 32.52% rise over the past year, significantly outperforming the Sensex. In the broader market context, Accent Microcell's short-term return of 5.38% over the past week is substantially higher than the Sensex's return of 0.68%, indicating str...

Read full news article

Why is Accent Microcell falling/rising?

2025-11-12 00:14:01

As of 11-Nov, Accent Microcell Ltd's stock price is rising, currently at 305.65, reflecting an increase of 10.55 or 3.58%. The stock has shown strong performance today, outperforming its sector by 1.79%. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Additionally, there has been a significant rise in investor participation, with delivery volume increasing by 96.77% compared to the 5-day average. The stock has also demonstrated impressive returns, with a 1-week increase of 6.46% and a 1-month increase of 20.33%, both significantly outperforming the Sensex. In the broader market context, Accent Microcell's short-term performance has been notably strong compared to the benchmark, with a 1-week return of 6.46% against the Sensex's 0.38%. This trend continues over the 1-month period, where the stock's return of 20.33% far exceeds the Sensex's 1....

Read full news article

View All News